Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey

Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey

Coronavirus disease 2019 (COVID-19) continues to pose a threat to public health with the potential for the emergence of new variants. Vaccines are the milestones to control and slow down the damage of the pandemic. As of January 2021, a two-dose regimen with CoronaVac was authorized in Turkey. Due t...

Full description

Bibliographic Details
Main Authors: Meliha Cagla Sonmezer, Gulcin Telli Dizman, Enes Erul, Taha Koray Sahin, Tuğba Saricaoglu, Alparslan Alp, Mine Durusu Tanriover, Omrum Uzun, Serhat Unal, Murat Akova
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Vaccines
Subjects:
COVID-19 vaccine
booster dose
third dose
vaccine effectiveness
Online Access:https://www.mdpi.com/2076-393X/10/7/1140

Similar Items

Similar Items